Physician
NPI deactivated
Quickmed Medical P.C.
Quickmed Medical P.C. was paid $9.87M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoQUICKMED MEDICAL P.C.
NEW YORK, NY 10128
NEW YORK, NY 10128
33aNPI1003253030assigned 05/31/2013
33bProvider typeEmergency Medical Services (Emergency Medicine) Physician
28Total paid$9.87M
24GClaims141,105
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medical Services (Emergency Medicine) Physician providers in New York
Rank by total paid#4 of 88
Median peer was paid$4K
This provider vs. median2,465×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,365 | $965K | |
| 2019 | 10,849 | $1.05M | |
| 2020 | 14,356 | $1.36M | |
| 2021 | 17,658 | $1.63M | |
| 2022 | 9,418 | $568K | |
| 2023 | 36,584 | $1.98M | |
| 2024incomplete | 41,875 | $2.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 38,769 | 33,102 | $3.73M |
| S9083 | Global fee urgent care centers | 19% | 20,821 | 17,358 | $1.90M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 18% | 18,070 | 17,932 | $1.73M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 14,457 | 13,460 | $1.41M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.1% | 7,022 | 7,012 | $696K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 1.1% | 6,075 | 5,352 | $111K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 864 | 771 | $72K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 11,180 | 10,513 | $68K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,223 | 3,531 | $36K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 271 | 271 | $28K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,997 | 2,930 | $22K |
| 81025 | <1% | 2,294 | 2,234 | $16K |
36 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 437 | $15K |
| 81003 | <1% | 1,856 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,140 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 271 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 703 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 274 | $2K |
| 81000 | <1% | 560 | $2K | |
| 93000 | <1% | 471 | $1K | |
| 87400 | <1% | 134 | $1K | |
| 99385 | <1% | 27 | $966.46 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 100 | $813.13 |
| 0012A | <1% | 33 | $764.31 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 36 | $735.24 |
| 87807 | <1% | 439 | $696.88 | |
| 0011A | <1% | 32 | $636.25 | |
| 90686 | <1% | 76 | $507.83 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 75 | $409.61 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 29 | $322.86 |
| 86580 | <1% | 84 | $241.20 | |
| 90656 | <1% | 43 | $220.66 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 82 | $204.80 |
| 73630 | <1% | 13 | $181.09 | |
| 73130 | <1% | 12 | $116.78 | |
| 81002 | <1% | 81 | $108.04 | |
| 86592 | <1% | 24 | $87.96 | |
| 73610 | <1% | 12 | $85.94 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 32 | $75.88 |
| 82962 | <1% | 58 | $72.91 | |
| 87340 | <1% | 32 | $72.65 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 59 | $69.36 |
| 87481 | <1% | 15 | $49.10 | |
| 86803 | <1% | 19 | $35.81 | |
| 99000 | <1% | 2,544 | $4.52 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 62 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 124 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 73 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEUTSCH, JASON (OWNER/PRESIDENT)